HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James Lowder, MD
Prometheus Labs
Principal Investigator - Sapna Patel, MD
MD Anderson
Principal Investigator - William Sharfman, MD
Johns Hopkins University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of Arizona Cancer Center
Tucson, Arizona, United States
- Moores Ucsd Cancer Center
La Jolla, California, United States
- Msmc Research Program
Miami Beach, Florida, United States
- Oncology Specialists, Sc
Park Ridge, Illinois, United States
- University of Iowa Hospitals & Clinics
Iowa City, Iowa, United States
- Johns Hopkins Medicine
Lutherville, Maryland, United States
- Karmanos Cancer Institute
Detroit, Michigan, United States
- Nebraska Cancer Specialists, Midwest Cancer Center - Legacy
Omaha, Nebraska, United States
- Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center
New York, New York, United States
- Duke University Health System
Durham, North Carolina, United States
- the Christ Hospital
Cincinnati, Ohio, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2013
- Primary completion
- 31 Jul 2015
- Completion
- 31 Jul 2015
- Last update posted
- 5 Dec 2023
- Registered enrollment
- 29
- Registry id
- NCT01856023
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.